Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate and Prednisolone in Post-Docetaxel mCRPC
NCT01685983Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Janssen Pharmaceutical. Started Aug 2011; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT01685983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01685983.